未登录

Y

Yajing Liu

Huazhong University of Science and Technology

H指数:15

被引数:652

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Roles and mechanisms of cuproptosis for reversing cancer therapeutic resistance

铜死亡在逆转癌症治疗抵抗中的作用与机制

International Journal of Pharmaceutics

IF5.2

2025-10-100

PRE

Traditional medicine Kuanxiong Aerosol alleviates atherosclerotic plaque inflammation by mitigating CX3CR1+ macrophage apoptosis via the cGAS–STING pathway

传统中药冠心气雾剂通过缓解cGAS–STING通路介导的CX3CR1+巨噬细胞凋亡来减轻动脉粥样硬化斑块炎症

IF8.3

2025-07-300

PRE

Doxorubicin induces deglycosylation of cancer cell-intrinsic PD-1 by NGLY1

IF3

2024-05-230

PRE

Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming: Erratum

IF13.3

2024-01-010

OAAI

The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2023-06-010

OAAI

Salinomycin induces autophagic cell death in salinomycin-sensitive melanoma cells through inhibition of autophagic flux

SCIENTIFIC REPORTS

IF3.9

2020-10-2815

OAAI

Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-05-0135

PREAI

Shear stress activates ATOH8 via autocrine VEGF promoting glycolysis dependent-survival of colorectal cancer cells in the circulation

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2020-01-3043

OAAI

Multifunctional Magnetic Nanoplatform Eliminates Cancer Stem Cells via Inhibiting the Secretion of Extracellular Heat Shock Protein 90

ADVANCED HEALTHCARE MATERIALS

IF9.6

2019-04-1018

PREAI

Design, synthesis, and structure-activity relationships of novel imidazo [4,5-c] pyridine derivatives as potent non-nucleoside inhibitors of hepatitis C virus NS5B

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2018-05-0120

PREAI

Design, synthesis and biological evaluation of novel 4-phenoxyquinoline derivatives containing 3-oxo-3,4-dihydroquinoxaline moiety as c-Met kinase inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2017-08-0132

PREAI

Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2016-11-0145

PREAI

Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2015-08-0134

PREAI

Design and optimization of novel 4-(2-fluorophenoxy)quinoline derivatives bearing a hydrazone moiety as c-Met kinase inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2014-11-0127

PREAI

Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2009-07-0126

PREAI

Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2008-07-0133

PRE